I'm prepared to accept it is a risk to the trial recruitment rate. But the gross impact is minimal (8 centres out of 29), so it isn't really worth worrying about. The bigger risk is that management and the board have set a recruitment rate target of 16 patients per quarter, which is significantly greater than 3, 3 and 6 we saw in the 9 months to September, 2024. The quarterly will be interesting!
- Forums
- ASX - By Stock
- CYP
- CYP Price Target post MSB FDA approval.
CYP
cynata therapeutics limited
Add to My Watchlist
2.94%
!
16.5¢

CYP Price Target post MSB FDA approval., page-175
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
16.5¢ | 17.0¢ | 16.5¢ | $39.66K | 238.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 277684 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 14285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 277684 | 0.165 |
6 | 607381 | 0.160 |
3 | 26451 | 0.155 |
3 | 115000 | 0.150 |
2 | 45937 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 14285 | 1 |
0.180 | 108494 | 4 |
0.185 | 94565 | 3 |
0.190 | 133868 | 2 |
0.195 | 19300 | 1 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |